EP 3313430 B1 20201118 - NOVEL THERAPEUTIC USE OF FGF19
Title (en)
NOVEL THERAPEUTIC USE OF FGF19
Title (de)
NEUARTIGE THERAPEUTISCHE VERWENDUNG VON FGF19
Title (fr)
NOUVELLE UTILISATION THÉRAPEUTIQUE DE FGF19
Publication
Application
Priority
- EP 15305990 A 20150625
- EP 2016064671 W 20160624
Abstract (en)
[origin: EP3108893A1] The present invention relates to a FGF19 polypeptide for its use in the prevention and/or treatment of loss of muscle mass in a mammal body.
IPC 8 full level
A61K 38/18 (2006.01); A61P 21/06 (2006.01)
CPC (source: EP US)
A61K 38/1825 (2013.01 - EP US); A61K 45/06 (2013.01 - EP); A61P 21/06 (2017.12 - EP); A61K 45/06 (2013.01 - US); A61K 2300/00 (2013.01 - US)
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
DOCDB simple family (publication)
EP 3108893 A1 20161228; CA 2997652 A1 20161229; EP 3313430 A1 20180502; EP 3313430 B1 20201118; JP 2018519366 A 20180719; JP 6761929 B2 20200930; US 10695403 B2 20200630; US 2018369331 A1 20181227; WO 2016207354 A1 20161229
DOCDB simple family (application)
EP 15305990 A 20150625; CA 2997652 A 20160624; EP 16733413 A 20160624; EP 2016064671 W 20160624; JP 2018518786 A 20160624; US 201615739238 A 20160624